Philadelphia tests FDA-approved drug for Alzheimer's disease in The AHEAD Study trial
A doctor with Keystone Clinical Studies in Plymouth Meeting is testing the drug lecanemab in the AHEAD trial to determine if it can also prevent Alzheimer's. It's already approved to treat early-stage memory loss.